Clinical Trial Update: Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concomitant chemoradiotherapy followed by MIDLE chemotherapy for stage I/II extranodal NK/T-cell lymphoma, nasal type; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• MIDLE chemotherapy

Snippet

Sponsor: Samsung Medical Center | Conditions: Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Status: COMPLETED